PTC Therapeutics, Inc.
PTCT· Nasdaq
Released Oct 27, 2022, after the close
10-Q filed Oct 27, 2022, 27 days after period end · 0001070081-22-000041
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Revenue | $217.13M | $138.74M | $118.40M | $71.42M |
| Net Income | -$109.32M | -$133.62M | -$69.69M | -$60.00M |
| EPS Diluted |
PTC Therapeutics, Inc. · CIK 1070081 · Engraved from SEC EDGAR
| -$1.53 |
| -$1.89 |
| -$1.03 |
| -$1.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.